Amundi lowered its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 2.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,105,298 shares of the industrial products company's stock after selling 123,627 shares during the quarter. Amundi owned about 2.19% of Xylem worth $603,609,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Wexford Capital LP purchased a new stake in shares of Xylem during the third quarter valued at about $27,000. Commonwealth Retirement Investments LLC purchased a new position in shares of Xylem in the 4th quarter worth approximately $27,000. Dunhill Financial LLC bought a new position in shares of Xylem during the 2nd quarter worth approximately $30,000. Avalon Trust Co bought a new position in shares of Xylem during the 2nd quarter worth approximately $35,000. Finally, Orion Capital Management LLC purchased a new stake in Xylem during the second quarter valued at approximately $35,000. Hedge funds and other institutional investors own 87.96% of the company's stock.
Analyst Ratings Changes
XYL has been the topic of several analyst reports. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Xylem in a report on Wednesday, August 5th. Mizuho increased their price objective on Xylem from $124.00 to $130.00 and gave the company a "neutral" rating in a report on Wednesday, July 29th. Barclays raised their price objective on Xylem from $154.00 to $159.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 29th. Royal Bank Of Canada boosted their target price on Xylem from $159.00 to $164.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 29th. Finally, Citigroup reaffirmed a "buy" rating on shares of Xylem in a research report on Wednesday, July 29th. Nine research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Xylem currently has an average rating of "Moderate Buy" and an average price target of $155.00.
View Our Latest Research Report on Xylem
Xylem Price Performance
Shares of XYL opened at $105.91 on Monday. The business's 50-day moving average is $117.60 and its two-hundred day moving average is $118.01. The company has a market capitalization of $24.73 billion, a P/E ratio of 25.22, a P/E/G ratio of 1.70 and a beta of 1.00. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.12. The business had revenue of $2.34 billion during the quarter, compared to analysts' expectations of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The company's revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Research analysts predict that Xylem Inc. will post 5.66 earnings per share for the current year.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Thursday, August 27th. Xylem's payout ratio is 40.95%.
Xylem Company Profile
(
Free Report)
Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.